Home LiteratureArticle Details
PMID: 24021253 Published · ppublish English

Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.

Meaney-Delman Dana, Bellcross Cecelia A

Abstract

An understanding of the diagnosis and clinical management of hereditary breast and ovarian cancer syndrome (HBOC) is essential for obstetricians/gynecologists. This article provides practical information regarding collecting a family history, cancer risk assessment and genetic testing, BRCA-associated cancer prognosis and treatment, screening recommendations, and prevention strategies. Through appropriate cancer risk assessment, women with BRCA1/2 mutations can be identified, and screening and prevention strategies can be used before a diagnosis of cancer occurs. Women's health providers with a strong working knowledge of HBOC are able to improve the quality of care for women and families impacted by BRCA1/2 mutations.

Keywords
BRCA1 BRCA2 Clinical management Genetic testing Hereditary breast cancer Hereditary ovarian cancer
Article Info
Journal
Obstetrics and gynecology clinics of North America
Abbr.
Obstet Gynecol Clin North Am
Published
2014-04-17
Indexed
2013-09-11
Updated
2013-09-11
Language
English
Country/Region
United States
NLM ID
8709551
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com